Increased soluble guanylate cyclase activity in the red blood cells of sickle cell patients

British Journal of Haematology

Volumn 124, Issue 4, 2004, Pages 547-554

  Conran, Nicola ^a   Oresco Santos, Camila ^a   Acosta, Heloisa C ^a   Fattori, André ^a   Saad, Sara T O ^a   Costa, Fernando F ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Erythrocytes; Hydroxyurea; Nitric oxide; Sickle cell anaemia; Soluble guanylate cyclase

Indexed keywords

CYCLIC GMP; GUANYLATE CYCLASE; HEMOGLOBIN F; HYDROXYUREA; NITRIC OXIDE; NITRIC OXIDE DONOR;

ADULT; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVATION; ENZYME ACTIVITY; ERYTHROCYTE; ERYTHROCYTE LEVEL; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION; HEMOGLOBIN DETERMINATION; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; RETICULOCYTE COUNT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD; SICKLE CELL ANEMIA;

ADULT; ANEMIA, SICKLE CELL; ANTISICKLING AGENTS; CHILD; CYCLIC GMP; ERYTHROCYTES; FEMALE; FETAL HEMOGLOBIN; GUANYLATE CYCLASE; HUMANS; HYDROXYUREA; MALE; MIDDLE AGED; NITRIC OXIDE DONORS; RETICULOCYTE COUNT; RETICULOCYTES; RNA, MESSENGER; SOLUBILITY;

EID: 1242315424     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2004.04810.x     Document Type: Article

References (31)

1. Buechler, W.A., Ivanova, K., Wolfram G., Drummer, C., Heim, J.M. & Gerzen, R. (1994) Soluble guanylate cyclase and platelet function. Annals of the New York Academy of Sciences, 714, 1151-1157.
2. Bustin, S.A. (2000) Absolute quantification of mRNA using real-time reverse transcription polymerase chain reactions assay. Journal of Molecular Endocrinology, 25, 169-193.
3. Charache, S., Torrin, M.L., Moore, R.D., Dover, G.J., Barton, F.B., Eckert, S.V., McMahon, R.P. & Bonds, D.R. (1995) Effect of hydroxyurea on frequency of painful crises in sickle cell anemia. Investigators of the multicenter study of hydroxyurea in sickle cell anemia. New England Journal of Medicine, 332, 1317-1322.
4. Cokic, V.P., Smith, R.D., Beleslin-Cokic, B.B., Njoroge, J.M., Miller, J.L., Gladwin, M.T. & Schechter, A.N. (2003) Hydroxyurea induces fetal hemoglobin by the nitric oxide-dependent activation of soluble guanylyl cyclase. Journal of Clinical Investigation, 111, 231-239.
5. Conran, N., Ferreira, H.H.A., Lorand-Metze, I., Thomazzi, S.M., Antunes, E. & de Nucci, G. (2001) Nitric oxide regulates human eosinophil adhesion mechanisms in vitro by changing integrin expression and activity on the eosinophil cell surface. British Journal of Pharmacology, 134, 632-638.
6. Denninger, J.W. & Marletta, M.A. (1999) Guanylate cyclase and the NO/cGMP signalling pathway. Biochimica et Biophysica acta, 1411, 334-350.
7. Gladwin, M.T. & Schechter, A.N. (2001) Nitric oxide therapy in sickle cell disease. Seminars in Hematology, 38, 333-342.
8. Gladwin, M.T., Ognibene, F.P., Pannell, L.K., Nichols, J.S., Pease-Fye M.E., Shelhamer, J.H. & Schechter, A.N. (2000) Relative role of heme nitrosylation and beta-cysteine 93 nitrosation in the transport and metabolism of nitric oxide by hemoglobin in the human circulation. Proceedings of the National Academy of Sciences of the United States of America, 97, 9943-9948.
9. Gladwin, M.T., Shelhamer, J.H., Ognibene, F.P., Pease-Fye, M.E., Nichols, J.S., Link, B., Patel, D.B., Jankowski, M.A., Pannell, L.K., Schechter, A.N. & Rodgers, G.P. (2002) Nitric oxide donor properties of hydroxyurea in patients with sickle cell disease. British Journal of Haematology, 116, 436-444.
10. Head, C.A., Brugnara, C., Martinez-Ruiz, R., Kacmarek, R.M., Bridges, K.R., Kuter, D., Bloch, K.D. & Zapol, W.M. (1997) Low concentrations of nitric oxide increase oxygen affinity of sickle erythrocytes in vitro and in vivo. Journal of Clinical Investigation, 100, 1193-1198.
11. Ikuta, T., Ausenda, S. & Cappellini, M.D. (2001) Mechanism for fetal globin gene expression: role of the soluble guanylate cyclase-cGMP-dependent protein kinase pathway. Proceedings of the National Academy of Sciences of the United States of America, 98, 1847-1852.
12. Kim-Shapiro, D.B., King, S.B., Shields, H., Kolibash, C.P., Gravatt, W.L. & Ballas, S.K. (1999) The reaction of deoxy-sickle cell hemoglobin with hydroxyurea. Biochimica et Biophysica acta, 1428, 381-387.
13. Kosonen, O., Kankaanranta, H., Malo-Ranta, U. & Moilanen, E. (1999) Nitric oxide-releasing compounds inhibit neutrophil adhesion to endothelial cells. European Journal of Pharmacology, 382, 111-117.
14. Lopez, B.L., Barnell, J., Balles, S.K., Christopher, T.A., Davis-Moon, L. & Ma, X. (1996) Nitric oxide metabolite levels in acute vasocclusive crisis. Academic Emergency Medicine, 3, 1098-1103.
15. Lopez, B.L., Davis-Moon, L., Ballas, S.K. & Ma, X.L. (2000) Sequential nitric oxide measurements during the emergency department treatment of acute vasoocclusive sickle cell crisis. American Journal of Hematology, 64, 15-19.
16. McDade, W.A., Shaba, H.M., Boler, N. & Mathies, S. (1997) Nitric oxide increases the solubility of deoxyhemoglobin S solutions and promotes unsickling of sickled cells. National Sickle Cell Disease Conference, 1, 252.
17. Morris, C.R., Kuypers, F.A., Larkin, S., Sweeters, N., Simon, J., Vichinsky, E.P. & Styles, L.A. (2000) Arginine therapy: a novel strategy to induce NO production in sickle cell disease. British Journal of Haematology, 111, 498-500.
18. Nahavandi, M., Wyche, M.Q., Perlin, E., Tavakkoli, F. & Castro, O. (2000) Nitric oxide metabolism in sickle cell anemia patients after oral administration of hydroxyurea. Hematology, 5, 335-339.
19. Nahavandi, M., Tavakkoli, F., Wyche, M.Q., Perlin, E., Winter, W.P. & Castro, O. (2002) Nitric oxide and cyclic GMP levels in sickle cell patients receiving hydroxyurea. British Journal of Haematology, 119, 855-857.
20. Olmos, L., Mombouli, J.V., Wasserstrum, N. & Vanhoutte, P.M. (2002) Ability of sickle cells to scavenge endothelium-derived nitric oxide is reduced. Acta Pharmacologia Sinica, 23, 967-973.
21. Pawloski, J.R., Hess, D.T. & Stamler, J.S. (2001) Export by red blood cells of nitric oxide bioactivity. Nature, 409, 622-626.
22. Petrov, V. & Lijnen, P. (1996) Regulation of human erythrocyte Na+/ H+ exchange by soluble and particulate guanylate cyclase. American Journal of Physiology, 271, C1556-C1564.
23. Pfaffl, M.W. (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Research, 29, e45.
24. Reiter, C.D., Wang, X., Tanus-Santos, J.E., Hogg, N., Cannon III, R.O., Schechter, A.N. & Gladwin, M.T. (2002) Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nature Medicine, 8, 1383-1389.
25. Serjeant, G.R. (1997) Sickle cell disease. Lancet, 350, 725-730.
26. Space, S.L., Lane, P.A., Pickett, C.K. & Weil, J.V. (2000) Nitric oxide attenuates normal and sickle red blood cell adherence to pulmonary endothelium. American Journal of Hematology, 63, 200-204.
27. Stamler, J.S., Jia, L., Eu, J.P., McMahon, T.J., Demchenko, I.T., Bonaventura, J., Gernert, K. & Piantadosi, C.A. (1997) Blood flow regulation by S-nitrosohemoglobin in the physiological oxygen gradient. Science, 276, 2034-2037.
28. Vichinsky, E. (2002) New therapies in sickle cell disease. Lancet, 360, 629-631.
29. Warner, T.D., Mitchell, J.A., Sheng, H. & Murad, F. (1994) Effects of cyclic GMP on smooth muscle relaxation. Advances in Pharmacology, 26, 171-194.
30. Yarbro, J.W. (1992) Mechanism of action of hydroxyurea. Seminars in Oncology, 19, 1-10.
31. Zabel, U., Weeger, M., Mylinh, L.A. & Schmidt H.H.W. (1998) Human soluble guanylate cyclase: functional expression and revised isoenzyme family. Biochemical Journal, 335, 51-57.